Audiomedica.com
Cabozantinib Better for VEGF Resistant Metastatic Renal Cell Carcinoma
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:00:06
- Mas informaciones
Informações:
Sinopsis
MILAN, Italy—The first choice of therapy for patients with metastatic kidney cancer who have failed VEGF therapy has changed according to experts at the 2016 European Multidisciplinary Meeting on Urological Cancers (EMUC) who assessed phase 3 study data on …Thomas Powles 1 EMUC PRODUCTION Master
